Marine glycoenzyme screening is a technology that focuses on the Directed Evolution of Glycoenzymes. Directed evolution experiments include three basic steps, namely library construction, screening, and gene amplification. Screening steps, if performed carelessly or inappropriately, result in no positive candidates. CD BioGlyco is committed to providing excellent Marine Glycoenzyme Development Services, of which marine glycoenzyme screening service is one of our core services. We provide suitable and reliable screening methods to identify variants of interest based on biochemical or biophysical readout assays, including but not limited to: agar plates, microtiter plates, fluorescence-activated cell sorting (FACS), chromatography, and mass spectrometry.
Fig.1 Marine glycoenzyme screening service. (CD BioGlyco)
CD BioGlyco provides clients with an agar plate-based marine glycoenzyme screening service, which uses the agar plate method to screen marine glycoenzymes to help clients quickly discover biologically active enzymes.
CD BioGlyco provides a microtiter plate-based marine glycoenzyme screening service, which uses microtiter plate technology to screen marine glycoenzymes and detect enzyme activity in a high-throughput manner to meet clients' scientific research needs.
With the help of FACS-based marine glycoenzyme screening, we quickly and accurately screen out marine glycoenzymes with specific functions, providing strong support for clients' drug development and biotechnology applications.
Through chromatography-based marine glycoenzyme screening, we provide clients with one-stop services for the isolation, purification, and identification of marine glycoenzymes, ensuring that the purity and activity of the enzyme meet client needs.
Using glycophage display system-based marine glycoenzyme screening service, we efficiently screen out marine glycoenzymes with potential application value, providing key support for clients' biotechnology research and development.
Technology: A microtiter plate-based screening assay
Journal: Organic & biomolecular chemistry
IF: 3.89
Published: 2017
Results: The authors developed a screening assay based on a microtiter plate that could accurately determine sialyltransferases' activity and regioselectivity. This tool was specifically used by the authors for screening two single-site saturation libraries of the α2-3-sialyltransferase 1 (PmST1) from Pasteurella multocida for any instances of α2-6-sialyltransferase activity, as well as overall sialyltransferase activity. The PmST1 variation that they found most effective in undertaking the role of an α2-6-sialyltransferase was the double mutant P34H/M144L. Compared to the PmST1 found in the wild type, this mutant demonstrated a 50% reduction in donor hydrolysis and the sialidase activity had been brought down by 50-fold. The interesting feature of this mutant was that it maintained the backdrop of promiscuity found in the donor substrate similar to the wild-type enzyme and was engaged efficiently in a one-pot multienzyme (OPME) system. This was specifically done to catalyze selectively the sialylation of the terminal galactose residue present in a multi galactose-containing tetrasaccharide, namely lacto-N-neotetraoside.
Here are some of the results shown in this article:
Fig.2 A high-throughput screening assay for identifying PmST1 mutants. (McArthur, et al., 2017)
At CD BioGlyco, we quickly and accurately screen out enzymes with excellent performance from a large number of mutant enzymes. We provide professional and efficient services whether it is agar plate-based, microtiter plate-based, or FACS-based screening. We are committed to continuously optimizing the screening process to provide clients with higher-quality services. You are welcome to
at any time to learn more about the marine glycoenzyme screening service.References